Form 8-K - Current report:
SEC Accession No. 0001144204-14-037449
Filing Date
2014-06-13
Accepted
2014-06-13 08:04:38
Documents
2
Period of Report
2014-06-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v381410_8k.htm 8-K 16335
2 EXHIBIT 99.1 v381410_ex99-1.htm EX-99.1 11205
  Complete submission text file 0001144204-14-037449.txt   29001
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 14908860
SIC: 2836 Biological Products, (No Diagnostic Substances)